IBD: Crohn's Disease
Webseminar: Understanding the Benefits and Risks of IBD Therapies
This empowering session reviewed the basics of IBD, outlined the benefits and risks of medications used to treat ulcerative colitis and Crohn’s disease and answered the many questions of attendees. Special thanks to Dr. Talat Bessissow for sharing his insights and expertise and to AbbVie Inc. for sponsoring our IBD Treatment Options Webseminar.
Related Articles
On June 26th CDHF sat down with three individuals who have been diagnosed with ulcerative colitis (UC) to learn all about what it is like to […]
Making informed decisions is imperative to your good health but understanding the benefits and risks associated with Ulcerative Colitis (UC) treatment options can be challenging. CDHF […]
Inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’ disease, is a chronic inflammatory disorder of the gastrointestinal tract. The prevalence of children with IBD […]